Definium Therapeutics, Inc. (DFTX)

16.80 -0.33 (-1.93%) USD  |  NASDAQ  |  Feb 23, 15:29
More

Definium Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for DFTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Pulse Biosciences, Inc. Upgrade
RxSight, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Nutriband, Inc. Upgrade